NBP608
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for NBP608, covering 2017-04-14 to 2019-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age [Phase 3]